Adult soft tissue Ewing sarcoma or primitive neuroectodermal tumors: Predictors of survival?

Archives of Surgery

Volumn 138, Issue 3, 2003, Pages 281-285

  Martin II, Robert C G ^a   Brennan, Murray F ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; IFOSFAMIDE; IRIDIUM 192;

ADOLESCENT; ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; EWING SARCOMA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROECTODERM TUMOR; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RISK FACTOR; SOFT TISSUE SARCOMA; TUMOR BIOPSY; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; SARCOMA, EWING'S; SOFT TISSUE NEOPLASMS;

EID: 0037336178     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.138.3.281     Document Type: Article

References (16)

1. Ewing J. Diffuse endothelioma of bone. Proc N Y Pathol Soc. 1921;21:17-24.
2. Aurias A, Rimbaut C, Buffe D, Dubousset J, Mazabraud A. Chromosomal translocations in Ewing's sarcoma. N Engl J Med. 1983;309:496-498.
3. Whang-Peng J, Triche TJ, Knutsen T, Miser J, Douglass EC, Israel MA. Chromosome translocation in peripheral neuroepithelioma. N Engl J Med. 1984;311:584-585.
4. Dierick AM, Roels H, Langlois M. The immunophenotype of Ewing's sarcoma: an immunohistochemical analysis. Pathol Res Pract. 1993;189:26-32.
5. Ladanyi M, Bridge JA. Contribution of molecular genetic data to the classification of sarcomas. Hum Pathol. 2000;31:532-538.
6. Llombart-Bosch A, Carda C, Peydro-Olaya A, et al. Soft tissue Ewing's sarcoma: characterization in established cultures and xenografts with evidence of a neuroectodermic phenotype. Cancer. 1990;66:2589-2601.
7. Percy C, Young JL Jr, Muir C, et al. Histology of cancer: SEER population-based data, 1973-1987 introduction. Cancer. 1995;75:140-146.
8. Falk S, Alpert M. Five-year survival of patients with Ewing's sarcoma. Surg Gynecol Obstet. 1967;124:319-324.
9. Bacci G, Ferrari S, Bertoni F, et al. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy. J Clin Oncol. 2000;18:4-11.
10. Hayes FA, Thompson El, Meyer WH, et al. Therapy for localized Ewing's sarcoma of bone. J Clin Oncol. 1989;7:208-213.
11. Nesbit ME Jr, Gehan EA, Burgert EO Jr, et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol. 1990;8:1664-1674.
12. Sinkovics JG, Plager C, Ayala AG, Lindberg RD, Samuels ML. Ewing sarcoma: its course and treatment in 50 adult patients. Oncology. 1980;37:114-119.
13. Siegel RD, Ryan LM, Antman KH. Adults with Ewing's sarcoma: an analysis of 16 patients at the Dana-Farber Cancer Institute. Am J Clin Oncol. 1988;11:614-617.
14. Bacci G, Ferrari S, Comandone A, et al. Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine years. Acta Oncol. 2000;39:111-116.
15. Verrill MW, Judson IR, Wiltshaw E, Thomas JM, Harmer CL, Fisher C. The use ofpaediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours. Ann Oncol. 1997;8:1099-1105.
16. Paulussen M, Ahrens S, Dunst J, et al. Localized Ewing tumor of bone. J Clin Oncol. 2001;19:1818-1829.